Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis

The central role of the propensity score in observational studies for causal effects

Paul R. Rosenbaum, Donald B. Rubin · Biometrika · 1983 · 31K citations · Full text

Public Health, Biostatistics, Causal Inference +16

Variable Selection for Propensity Score Models

M. Alan Brookhart, Sebastian Schneeweiß, Kenneth J. Rothman et al. · American Journal of Epidemiology · 2006 · 2.3K citations · Full text

Public Health, Biostatistics, Causal Inference +16

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Medicine, Dermatology, Immunology +12

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

Wayne A. Ray · American Journal of Epidemiology · 2003 · 1.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Guidelines of care for the management of atopic dermatitis

Lawrence F. Eichenfield, Wynnis L. Tom, Timothy G. Berger et al. · Journal of the American Academy of Dermatology · 2014 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +12